Related Experiment Video
Updated: Jul 12, 2026
07:47
Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research
Published on: December 25, 2021
Advancements in Circulating Tumor Cell Expansion Ex Vivo: A Matured Technology?
1Department of Internal Medicine, University of California, San Francisco, CA, USA. Jerry.Xiao@UCSF.edu.
Methods in Molecular Biology (Clifton, N.J.)
|July 9, 2026
Summary
Recent technological advances allow researchers to culture circulating tumor cells (CTCs) ex vivo. This enables deeper study into metastasis and the potential for personalized cancer medicine.
Area of Science:
- Oncology
- Cell Biology
- Cancer Metastasis Research
Background:
- Circulating tumor cells (CTCs) are key drivers of cancer metastasis.
- Early CTC research focused on cell counting, limiting mechanistic insights.
- Recent ex vivo CTC expansion techniques have revolutionized metastasis research.
Purpose of the Study:
- To review technological advancements in CTC isolation and propagation.
- To discuss different eras and strategies in CTC culture.
- To explore the development and utility of CTC-derived xenograft (CDX) models.
Main Methods:
- Highlighting two eras of CTC culture: epithelial cell growth and heterogeneity modeling (e.g., CTC clusters).
- Exploring methods for generating in vivo CTC-derived xenograft (CDX) models.
- Comparing and contrasting various CTC culture and xenograft modeling techniques.
Main Results:
- Technological progress has enabled viable CTC expansion ex vivo.
- New methods allow for the study of CTC heterogeneity and cluster formation.
- CTC-derived xenograft models provide in vivo platforms for metastasis research.
Conclusions:
- Advancements in CTC isolation and culture are crucial for understanding metastasis.
- CTC expansion technologies are vital for developing accurate metastasis models.
- CTC expansion holds significant promise for advancing personalized cancer medicine.
